Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inguinal Hernia Treatment: Stationary/Inpatient vs. Ambulatory/Outpatient Setting - HerStAmb Study (Prospective Non-randomized Multicenter Comparative Study)

NCT05234242 is registered in ClinicalTrials.gov with Dr. Michal Ziga as lead sponsor.

NCT NCT05234242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05234242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inguinal Hernia Treatment: Stationary/Inpatient vs. Ambulatory/Outpatient Setting - HerStAmb Study (Prospective Non-randomized Multicenter Comparative Study)
Lead sponsor
Dr. Michal Ziga
Phase
Observational
Overall status
Completed
Start date
January 1, 2019
Completion date
April 1, 2020
Enrollment
237 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

outcome of outpatient/ambulatory and inpatient/stationary setting